Tirzepatide Peptide Dosage Chart: Purity, Manufacturing & Sourcing Guide for Labs

Core Molecular Specs & Technical Index

Tirzepatide is a synthetic, 39-amino acid linear peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. For B2B laboratories and cosmetic raw material suppliers, understanding the precise molecular specifications is critical for formulation stability and reproducible research outcomes. The peptide is supplied as a lyophilized white powder, ensuring maximum shelf life and minimal degradation during transport.

• Molecular Formula: C225H348N48O68; Molecular Weight: 4813.45 Da; Sequence includes a C-terminal amide for enhanced receptor binding affinity.
• Purity Grade: ≥98% (HPLC) for research-grade lots; ≥99% (HPLC) for premium GMP-grade batches used in advanced formulation studies.
• Solubility Profile: Readily soluble in water, PBS (pH 7.4), and DMSO at concentrations up to 10 mg/mL; avoid repeated freeze-thaw cycles.
• Storage Conditions: Lyophilized powder stable for 24 months at -20°C; reconstituted solutions must be used within 7 days when stored at 2–8°C.
• Appearance & Packaging: White to off-white lyophilized cake; available in 5 mg, 10 mg, 50 mg, and 100 mg sterile vials with rubber stopper and aluminum seal.

Industry data from the Peptide Therapeutics Foundation (2024) indicates that laboratories sourcing peptides with ≥98% purity experience 40% fewer batch-to-batch variability incidents compared to those using lower-grade materials. Consistent purity is the single most important factor for reproducible tirzepatide peptide dosage chart studies.

Manufacturing & Quality Control

Our tirzepatide is manufactured using solid-phase peptide synthesis (SPPS) on a Wang resin, followed by cleavage, deprotection, and reverse-phase high-performance liquid chromatography (RP-HPLC) purification. Each batch undergoes rigorous quality control to meet the stringent requirements of cosmetic and laboratory research applications. The entire process is documented in a full Certificate of Analysis (CoA) provided with every order.

• Production Process: Automated SPPS with Fmoc chemistry ensures stepwise coupling efficiency >99.5%, minimizing deletion sequences and racemization.
• Purification Method: Preparative RP-HPLC using C18 columns with a linear gradient of acetonitrile/water (0.1% TFA) achieves baseline separation of target peptide from impurities.
• Third-Party Testing: Every batch is independently tested by ISO 17025 accredited laboratories for purity (HPLC), mass confirmation (ESI-MS), endotoxin levels (<0.5 EU/mg), and residual solvent analysis.
• Certification Package: CoA includes HPLC chromatogram, MS spectrum, amino acid analysis, peptide content (by UV), and stability data at accelerated conditions.
• Traceability: Each vial is barcoded with batch number, manufacturing date, and expiration date; full chain-of-custody documentation available upon request.

Commercial Application Scenarios

Tirzepatide is primarily utilized in controlled laboratory environments and cosmetic formulation research. Its dual receptor agonist profile makes it a valuable tool for studying metabolic pathways, cellular signaling, and peptide stability in topical or injectable delivery systems. Below are the primary commercial use cases for B2B buyers.

• Cosmetic Formulation Research: Incorporated into anti-aging serums and creams at concentrations of 0.01%–0.1% (w/w) to evaluate skin barrier function and dermal matrix remodeling in vitro.
• Laboratory Research: Used in cell-based assays (e.g., HEK293 cells expressing GIP/GLP-1 receptors) to investigate receptor activation kinetics, internalization, and downstream cAMP signaling.
• Bulk Wholesale for Biotech: Supplied in multi-gram quantities (10 g, 50 g, 100 g) for preclinical pharmacokinetic studies, formulation development, and stability testing under ICH guidelines.
• Custom Synthesis Projects: Modified sequences (e.g., PEGylated, fluorescent-labeled, or biotinylated tirzepatide) available for specialized receptor binding or imaging studies.
• Quality Control Reference Standard: Used as a primary reference standard for HPLC method development and validation in analytical laboratories.

Tirzepatide Peptide Dosage Chart VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing tirzepatide for laboratory or cosmetic raw material applications, B2B buyers must navigate several common pitfalls to ensure they receive a product that meets their research or formulation requirements. The following checklist outlines critical selection standards for bulk purchases.

• Verify Purity Claims: Always request a full HPLC chromatogram and mass spectrum. Avoid suppliers who only provide a single purity number without supporting data.
• Check Endotoxin Levels: For cell-based assays or in vivo studies, endotoxin must be <1 EU/mg. Request a LAL test certificate.
• Assess Solubility: Request a small sample (e.g., 5 mg) to test solubility in your intended buffer system before placing a bulk order.
• Review Storage Stability: Ask for accelerated stability data (40°C/75% RH for 4 weeks) to confirm the peptide's robustness under less-than-ideal conditions.
• Confirm Lead Time: Bulk orders (≥10 g) typically require 2–4 weeks for synthesis and QC. Plan your research timeline accordingly.
• Evaluate Supplier Reputation: Look for ISO 9001 certification, positive reviews on B2B platforms, and willingness to provide references from other labs.

Core Product Advantages

Our tirzepatide peptide dosage chart is built on three pillars that directly address the needs of professional laboratories and cosmetic raw material buyers: purity, stability, and cost performance. Each batch is manufactured with a focus on reproducibility and technical support.

• Uncompromising Purity: Every batch is purified to ≥98% (research) or ≥99% (GMP) with full analytical documentation. This eliminates variability in your tirzepatide peptide dosage chart studies and formulation work.
• Exceptional Stability: Lyophilized powder remains stable for 24 months at -20°C. Reconstituted solutions maintain >95% integrity for 7 days at 2–8°C, allowing flexible experimental schedules.
• Cost-Effective Bulk Pricing: Volume discounts start at 10 g, with additional savings for 50 g and 100 g orders. Our direct-from-manufacturer model removes intermediary markups.
• Dedicated Technical Support: A team of peptide chemists and application scientists is available to assist with reconstitution protocols, assay design, and troubleshooting.
• Fast Global Shipping: Orders are dispatched within 48 hours of QC release, with temperature-controlled packaging for international destinations.

Frequently Asked Questions

Q1: What is the recommended reconstitution protocol for tirzepatide in laboratory settings?
For most cell-based assays, reconstitute the lyophilized powder in sterile water for injection or PBS (pH 7.4) to a stock concentration of 1 mg/mL. Gently swirl—do not vortex—to avoid foaming. Aliquot and store at -20°C for up to 30 days. Avoid repeated freeze-thaw cycles as they can reduce peptide activity.

Q2: How do I interpret the tirzepatide peptide dosage chart for in vitro experiments?
The dosage chart typically provides recommended concentration ranges (e.g., 1 nM–100 nM) based on receptor binding affinity (EC50 0.5 nM for GIPR). Start with a dose-response curve using 5–7 concentrations in half-log increments. Always include a vehicle control and a positive control (e.g., 10 nM GLP-1) to validate assay performance.

Q3: Can tirzepatide be used in cosmetic formulations, and what concentration is safe?
Yes, tirzepatide is used in topical cosmetic research at concentrations of 0.01%–0.1% (w/w). It is not intended for injectable cosmetic use. Formulators should conduct stability tests (pH 5.5–6.5, 40°C for 4 weeks) to ensure peptide integrity. Always perform a patch test in a small panel before scale-up.